Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 1, 2021, Pluristem Therapeutics Inc., or the Company, held its 2021 Annual Meeting of Stockholders, or the 2021 Annual Meeting. The results of stockholder voting at the 2021 Annual Meeting are set forth below:

Proposal No. 1 - Election of Directors

The stockholders elected the following individuals as directors of the Company to hold office until the next annual meeting of shareholders and until their successors shall have been duly elected and qualified.





Director Name                  For           Against       Abstain       Broker Non-Votes
Zami Aberman                 9,921,167         173,259       10,617              5,220,994

Mark Germain                 5,755,350       4,338,868       10,825              5,220,994

Moria Kwiat                  6,001,421       4,093,061       10,561              5,220,994

Maital Shemesh-Rasmussen     9,988,263         104,990       11,794              5,220,990

Rami Levi                    9,905,005         189,258       10,788              5,220,985

Doron Shorrer                5,717,794       4,376,450       10,795              5,220,998

Yaky Yanay                   9,918,727         175,815       10,501              5,220,994

Proposal No. 2 - Ratification of the selection of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2021.





   For       Against   Abstain   Broker Non-Votes
15,115,914   193,797   16,326          N/A

Proposal No. 3 -Approval, by a nonbinding advisory vote, of the compensation of the Company's named executive officers.





   For       Against    Abstain   Broker Non-Votes
8,961,227   1,111,925   31,891       5,220,994

The results reported above are final voting results.





                                       1

© Edgar Online, source Glimpses